S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in
CVE:EKG

CardioComm Solutions, Inc. (EKG.V) Stock Forecast, Price & News

C$0.06
0.00 (0.00 %)
(As of 01/15/2021 05:41 PM ET)
Add
Compare
Today's Range
C$0.05
Now: C$0.06
C$0.06
50-Day Range
C$0.00
MA: C$0.04
C$0.08
52-Week Range
C$0.03
Now: C$0.06
C$0.11
Volume106,500 shs
Average Volume384,340 shs
Market CapitalizationC$8.06 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company's technology is used in a range of products for the recording, transmission, viewing, analyzing, reporting, and storage of ECGs for arrhythmia screening, diagnosis, and management of cardiac patients. Its systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals, and call centers to access and manage patient information. The company's software products include Global ECG Management System (GEMS), a software solution for cardiac event monitoring; GlobalCardio 12 Lead, a web enabled ECG device that is EMR compatible; and GEMS Lite for Windows, an electronic ECG receiving system. It also offers software modules, such as GEMS WIN Air, a live wireless ECG monitoring solution; AutoAttendant, which allows healthcare providers to focus on providing patient care; GEMS HL7 and EMR Interface that allows patient and follow-up information to be sent in an HL7 message format to other EMR systems that are HL7 compliant; and GlobalCardio EMR integration that enables bidirectional movement of data, including patient information, reports, and links. In addition, the company provides hardware products comprising HeartCheck PEN and HeartCheck, which are handheld ECG monitors; and Sirona telephonic and wireless event recorders. Further, it offers ASP services, including C4 ECG management services; and HeartCheck SMART Monitoring, an ECG reading service. Additionally, the company provides other products comprising GlobalCardio 3 Lead; ECG Viewer SDK; QRS Diagnostic; and QRS 12 Lead Universal products. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.

MarketRank

Overall MarketRank

0.50 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+1-416-9779425
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$770,296.00
Cash FlowC$0.00 per share
Book ValueC($0.01) per share

Profitability

Miscellaneous

Market CapC$8.06 million
Next Earnings DateN/A
OptionableNot Optionable
C$0.06
0.00 (0.00 %)
(As of 01/15/2021 05:41 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EKG News and Ratings via Email

Sign-up to receive the latest news and ratings for EKG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CardioComm Solutions, Inc. (EKG.V) (CVE:EKG) Frequently Asked Questions

How has CardioComm Solutions, Inc. (EKG.V)'s stock price been impacted by COVID-19?

CardioComm Solutions, Inc. (EKG.V)'s stock was trading at C$0.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, EKG shares have increased by 37.5% and is now trading at C$0.06.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than CardioComm Solutions, Inc. (EKG.V)?

Wall Street analysts have given CardioComm Solutions, Inc. (EKG.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CardioComm Solutions, Inc. (EKG.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of CardioComm Solutions, Inc. (EKG.V)'s key competitors?

Who are CardioComm Solutions, Inc. (EKG.V)'s key executives?

CardioComm Solutions, Inc. (EKG.V)'s management team includes the following people:
  • Mr. Etienne Grima, CEO, Corp. Sec. & Director
  • Mr. Simi Grosman, Independent Consultant & Director
  • Ms. Josee Bertrand, Chief Financial Officer

What is CardioComm Solutions, Inc. (EKG.V)'s stock symbol?

CardioComm Solutions, Inc. (EKG.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EKG."

How do I buy shares of CardioComm Solutions, Inc. (EKG.V)?

Shares of EKG and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is CardioComm Solutions, Inc. (EKG.V)'s stock price today?

One share of EKG stock can currently be purchased for approximately C$0.06.

How big of a company is CardioComm Solutions, Inc. (EKG.V)?

CardioComm Solutions, Inc. (EKG.V) has a market capitalization of C$8.06 million and generates C$770,296.00 in revenue each year.

What is CardioComm Solutions, Inc. (EKG.V)'s official website?

The official website for CardioComm Solutions, Inc. (EKG.V) is www.cardiocommsolutions.com.

How can I contact CardioComm Solutions, Inc. (EKG.V)?

CardioComm Solutions, Inc. (EKG.V)'s mailing address is 259 Yorkland Rd 2nd Floor, NORTH YORK, ON M2J 0B5, Canada. The company can be reached via phone at +1-416-9779425.

This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.